Colchicine Effect on Perivascular Inflammation Index on Coronary CTA
40 patients around the world
Available in Brazil
A single-center, prospective, single-blind randomized study to evaluate the efficacy of
colchicine versus placebo in patients with documented FAI ≥ -70.1 HU of the proximal segment
of the right coronary artery and/ou left anterior descending coronary artery and
non-calcified or mixed plaques on coronary angiography performed electively after 12-month
follow-up.
